EQUATE(TM) AQR APO AL/B DUO CONTROL

Lipoprotein, Low-density, Antigen, Antiserum, Control

BINAX, INC.

The following data is part of a premarket notification filed by Binax, Inc. with the FDA for Equate(tm) Aqr Apo Al/b Duo Control.

Pre-market Notification Details

Device IDK903122
510k NumberK903122
Device Name:EQUATE(TM) AQR APO AL/B DUO CONTROL
ClassificationLipoprotein, Low-density, Antigen, Antiserum, Control
Applicant BINAX, INC. 95 DARLING AVE. S. Portland,  ME  04106
ContactDavid E Kelsey
CorrespondentDavid E Kelsey
BINAX, INC. 95 DARLING AVE. S. Portland,  ME  04106
Product CodeDFC  
CFR Regulation Number866.5600 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1990-07-16
Decision Date1990-08-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.